Iowa House Bill HF852

Iowa 2025-2026 Regular Session

• Introduced: 3/7/25

Caption

A bill for an act relating to pharmacy benefits managers, pharmacies, and prescription drugs and including applicability provisions.(Formerly HSB 99.)

Impact

This legislation has significant implications for state laws governing the pharmaceutical industry. By enforcing a pass-through pricing model and prohibiting spread pricing, HF852 seeks to create greater transparency in drug pricing. Under this model, PBMs must pass on all payments received to the pharmacies, preventing practices where PBMs profit from the difference between charged and reimbursed prices. This change is expected to positively influence the business operations of pharmacies, particularly independent ones, by ensuring they receive fair compensation for their services.

Summary

House File 852 focuses on regulating pharmacy benefits managers (PBMs) and ensuring fair practices towards pharmacies and pharmacists in Iowa. The bill outlines several prohibitions against PBMs, including discrimination against pharmacies regarding participation in health plans, reimbursement rates, and conditions for policy engagement. It aims to enhance pharmacy access by mandating that covered persons can select their preferred pharmacy without undue financial penalties, thereby fostering consumer choice in the healthcare system.

Contention

Notably, there are points of contention surrounding the bill, specifically regarding its potential impact on the relationship between PBMs and pharmacies. Some stakeholders argue that while the bill promotes fairness, it may lead to unintended consequences, such as increased costs for third-party payors or health plans. Additionally, the requirement for an appeals process for pharmacies regarding reimbursement rates may introduce complexity into the already intricate landscape of pharmacy operations, potentially straining resources for smaller entities.